Host Cellular Response during Enterohaemorrhagic Escherichia coli Shiga Toxin Exposure

키워드

참고문헌 (153)

1. Lee MS, "Roles of shiga toxins in immunopathology", Toxins(Basel), 11, pp.212~ (2019)
2. Park JY, "Shiga toxins induce apoptosis and ER stress in human retinal pigment epithelial cells", Toxins(Basel), 9, pp.319~ (2017)
3. Lee KS, "Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells", Cell. Microbiol, 22, pp.e13249~ (2020)
4. Heredia N, "Animals as sources of food-borne pathogens : A review", Anim. Nutr, 4, pp.250~255 (2018)
5. Griffin PM, "The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome", Epidemiol. Rev, 13, pp.60~98 (1991)
6. Majowicz SE, "Global incidence of human Shiga toxinproducing Escherichia coli infections and deaths : a systematic review and knowledge synthesis", Foodborne Pathog. Dis, 11, pp.447~455 (2014)
7. Tarr PI, "Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome", Lancet, 365, pp.1073~1086 (2005)
8. Kaper JB, "Pathogenic Escherichia coli", Nat. Rev. Microbiol, 2, pp.123~140 (2004)
9. Havelaar AH, "World health organization global estimates and regional comparisons of the burden of foodborne disease in 2010", PLoS Med, 12, pp.e1001923~ (2015)
10. Fukushima H, "Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996", Pediatr. Int, 41, pp.213~217 (1999)
11. Bielaszewska M, "Shiga toxin-negative attaching and effacing Escherichia coli : distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution", Clin. Infect. Dis, 47, pp.208~217 (2008)
12. Pires SM, "Global and regional source attribution of Shiga toxin-producing Escherichia coli infections using analysis of outbreak surveillance data", Epidemiol. Infect, 147, pp.e236~ (2019)
13. Erickson MC, "Food as a vehicle for transmission of Shiga toxin-producing Escherichia coli", J. Food Prot, 70, pp.2426~2449 (2007)
14. Persad AK, "Animal reservoirs of Shiga toxinproducing Escherichia coli", Microbiol. Spectr, 2 (2014)
15. Espinosa L, "A scoping review on the prevalence of Shiga-toxigenic Escherichia coli in wild animal species", Zoonoses Public Health, 65, pp.911~920 (2018)
16. Kim JS, "Recent updates on outbreaks of Shiga toxin-producing Escherichia coli and its potential reservoirs", Front. Cell Infect. Microbiol, 10, pp.273~ (2020)
17. LeJeune JT, "Livestock drinking water microbiology and the factors influencing the quality of drinking water offered to cattle", J. Dairy Sci, 84, pp.1856~1862 (2001)
18. Caprioli A, "Enterohaemorrhagic Escherichia coli : emerging issues on virulence and modes of transmission", Vet. Res, 36, pp.289~311 (2005)
19. Gyles CL, "Shiga toxin-producing Escherichia coli : an overview", J. Anim. Sci, 85, pp.E45~E62 (2007)
20. Ferens WA, "Escherichia coli O157 : H7 : animal reservoir and sources of human infection", Foodborne Pathog. Dis, 8, pp.465~487 (2011)
21. Pruimboom-Brees IM, "Cattle lack vascular receptors for Escherichia coli O157 : H7 Shiga toxins", Proc. Natl. Acad. Sci. USA, 97, pp.10325~10329 (2000)
22. Galiero G, "Isolation of verocytotoxin-producing Escherichia coli O157 from water buffaloes(Bubalus bubalis)in southern Italy", Vet. Rec, 156, pp.382~383 (2005)
23. French E, "Enteric bacterial pathogens with zoonotic potential isolated from farmraised deer", Foodborne Pathog. Dis, 7, pp.1031~1037 (2010)
24. Chandran A, "Prevalence of diarrhea-associated virulence genes and genetic diversity in Escherichia coli isolates from fecal material of various animal hosts", Appl. Environ. Microbiol, 79, pp.7371~7380 (2013)
25. Mohammed Hamzah A, "Isolation of Escherichia coli 0157 : H7 strain from fecal samples of zoo animal", ScientificWorldJ, 2013, pp.843968~ (2013)
26. Nyholm O, "Hybrids of shigatoxigenic and enterotoxigenic Escherichia coli(STEC", ETEC)among human and animal isolates in Finland, 2015, pp.62, 518~524
27. Beutin L, "Prevalence and some properties of verotoxin(Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals", J. Clin. Microbiol, 31, pp.2483~2488 (1993)
28. DeVinney R, "Enterohemorrhagic Escherichia coli O157 : H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated", Infect. Immun, 67, pp.2389~2398 (1999)
29. Jerse AE, "A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells", Proc. Natl. Acad. Sci. USA, 87, pp.7839~7843 (1990)
30. Kenny B, "Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells", Cell, 91, pp.511~520 (1997)
31. Nagy B, "Enterotoxigenic Escherichia coli in veterinary medicine", Int. J. Med. Microbiol, 295, pp.443~454 (2005)
32. Melton-Celsa AR, "Shiga Toxin (Stx) csification, structure, and function", Microbiol. Spectr, 2 (2014)
33. Plunkett G, 3rd, "Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157 : H7 : Shiga toxin as a phage late-gene product", J. Bacteriol, 181, pp.1767~1778 (1999)
34. Krϋger A, "Shiga toxins and stx phages : highly diverse entities", Microbiology(Reading), 161, pp.451~462 (2015)
35. Coburn B, "Type III secretion systems and disease", Clin. Microbiol. Rev, 20, pp.535~549 (2007)
36. McDaniel TK, "A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens", Proc. Natl. Acad. Sci. USA, 92, pp.1664~1668 (1995)
37. Dean P, "The effector repertoire of enteropathogenic E. coli: ganging up on the host cell", Curr. Opin. Microbiol, 12, pp.101~109 (2009)
38. Brunder W, "KatP, a novel catalaseperoxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7", Microbiology (Reading), 142(Pt 11), pp.3305~3315 (1996)
39. Brunder W, "EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157 : H7 cleaves human coagulation factor V", Mol. Microbiol, 24, pp.767~778 (1997)
40. Scheutz F, "Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature", J. Clin. Microbiol, 50, pp.2951~2963 (2012)
41. Bai X, "Identification and pathogenomic analysis of an Escherichia coli strain producing a novel Shiga toxin 2 subtype", Sci. Rep, 8, pp.6756~ (2018)
42. Lacher DW, "Use of the Escherichia coli identification microarray for characterizing the health risks of Shiga toxin-producing Escherichia coli Isolated from foods", J. Food Prot, 79, pp.1656~1662 (2016)
43. Fao, "Who Stec Expert G.", Hazard identification and characterization:Criteria for categorizing Shiga toxin-producing Escherichia coli on a risk basis(dagger), 2019, pp.82, 7~21
44. Ng TB, "Recent progress in research on ribosome inactivating proteins", Curr. Protein Pept. Sci, 11, pp.37~53 (2010)
45. Endo Y, "Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA Nglycosidase activity of the toxins", Eur. J. Biochem, 171, pp.45~50 (1988)
46. Ling H, "Structure of the shiga-like toxin I Bpentamer complexed with an analogue of its receptor Gb3", Biochemistry, 37, pp.1777~1788 (1998)
47. Ståhl AL, "A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles", PLoS Pathog, 11, pp.e1004619~ (2015)
48. Watanabe-Takahashi M, "Exosome-associated Shiga toxin 2 is released from cells and causes severe toxicity in mice", Sci. Rep, 8, pp.10776~ (2018)
49. Brigotti M, "Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils", J. Immunol, 191, pp.4748~4758 (2013)
50. Schϋller S, "Shiga toxin binding in normal and inflamed human intestinal mucosa", Microbes Infect, 9, pp.35~39 (2007)
51. Zoja C, "The role of the endothelium in hemolytic uremic syndrome", J. Nephrol, 4, pp.S58~S62 (2001)
52. Goldstein J, "Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations : an ultrastructural study", Brain Res, 1161, pp.106~115 (2007)
53. Obrig TG, "Escherichia coli Shiga toxin mechanisms of action in renal disease", Toxins(Basel), 2, pp.2769~2794 (2010)
54. Bosse M, "Shiga toxin binding alters lipid packing and the domain structure of Gb3-containing membranes : a solid-state NMR study", Phys. Chem. Chem. Phys, 21, pp.15630~15638 (2019)
55. Okuda T, "Targeted disruption of Gb3", CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins, 2006, pp.281, 10230~10235
56. van de Kar NC, "Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells : implications for the pathogenesis of the hemolytic uremic syndrome", Blood, 80, pp.2755~2764 (1992)
57. Zumbrun SD, "Dietary choice affects Shiga toxin-producing Escherichia coli(STEC)O157 : H7 colonization and disease", Proc. Natl. Acad. Sci. USA, 110, pp.E2126~E2133 (2013)
58. Sandvig K, "Endocytosis from coated pits of Shiga toxin : a glycolipid-binding protein from Shigella dysenteriae 1", J. Cell Biol, 108, pp.1331~1343 (1989)
59. Lauvrak SU, "Shiga toxin regulates its entry in a Sykdependent manner", Mol. Biol. Cell, 17, pp.1096~1109 (2006)
60. Torgersen ML, "The A-subunit of surface-bound Shiga toxin stimulates clathrin-dependent uptake of the toxin", FEBS J, 272, pp.4103~4113 (2005)
61. Lauvrak SU, "Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin", J. Cell Sci, 117, pp.2321~2331 (2004)
62. Saint-Pol A, "Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes", Dev. Cell, 6, pp.525~538 (2004)
63. Renard HF, "Shiga toxin stimulates clathrin-independent endocytosis of the VAMP2, VAMP3 and VAMP8 SNARE proteins", J. Cell Sci, 128, pp.2891~2902 (2015)
64. Malyukova I, "Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis", Am. J. Physiol. Gastrointest. Liver Physiol, 296, pp.G78~G92 (2009)
65. Lombardi D, "Rab9 functions in transport between late endosomes and the trans Golgi network", EMBO J, 12, pp.677~682 (1993)
66. Itin C, "A novel assay reveals a role for soluble N-ethylmaleimide-sensitive fusion attachment protein in mannose 6-phosphate receptor transport from endosomes to the trans Golgi network", J. Biol. Chem, 272, pp.27737~27744 (1997)
67. Itin C, "Mapmodulin, cytoplasmic dynein, and microtubules enhance the transport of mannose 6-phosphate receptors from endosomes to the trans-golgi network", Mol. Biol. Cell, 10, pp.2191~2197 (1999)
68. Miwako I, "Cholesterol requirement for cation-independent mannose 6-phosphate receptor exit from multivesicular late endosomes to the Golgi", J. Cell Sci, 114, pp.1765~1776 (2001)
69. Iversen TG, "Endosome to Golgi transport of ricin is independent of clathrin and of the Rab9-and Rab11-GTPases", Mol. Biol. Cell, 12, pp.2099~2107 (2001)
70. Sandvig K, "Pathways followed by ricin and Shiga toxin into cells", Histochem. Cell Biol, 117, pp.131~141 (2002)
71. Lauvrak SU, "Selective regulation of the Rab9-independent transport of ricin to the Golgi apparatus by calcium", J. Cell Sci, 115, pp.3449~3456 (2002)
72. Mallard F, "Direct pathway from early", recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin Bfragment transport, 1998, pp.143, 973~990
73. Wilcke M, "Rab11 regulates the compartmentalization of early endosomes required for efficient transport from early endosomes to the trans-golgi network", J. Cell Biol, 151, pp.1207~1220 (2000)
74. Utskarpen A, "SNX1 and SNX2 mediate retrograde transport of Shiga toxin", Biochem. Biophys. Res. Commun, 358, pp.566~570 (2007)
75. Johannes L, "Tracing the retrograde route in protein trafficking", Cell, 135, pp.1175~1187 (2008)
76. Jackson ME, "The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum", J. Cell Sci, 112(Pt 4), pp.467~475 (1999)
77. White J, "Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells", J. Cell Biol, 147, pp.743~760 (1999)
78. Girod A, "Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum", Nat. Cell Biol, 1, pp.423~430 (1999)
79. Chan YS, "Shiga toxins : from structure and mechanism to applications", Appl. Microbiol. Biotechnol, 100, pp.1597~1610 (2016)
80. Amessou M, "Retrograde delivery of photosensitizer(TPPp-O-beta-GluOH)3 selectively potentiates its photodynamic activity", Bioconjug. Chem, 19, pp.532~538 (2008)
81. Garred O, "Role of the disulfide bond in Shiga toxin A-chain for toxin entry into cells", J. Biol. Chem, 272, pp.11414~11419 (1997)
82. Nowakowska-Gołacka J, "Toxins utilize the endoplasmic reticulum-associated protein degradation pathway in their intoxication process", Int. J. Mol. Sci, 20, pp.1307~ (2019)
83. Yu M, "Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ", ERdj3, 2005, pp.73, 2524~2532
84. Elmore S, "Apoptosis : a review of programmed cell death", Toxicol. Pathol, 35, pp.495~516 (2007)
85. Ching JC, "Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose)polymerase via in vitro activation of caspases", Infect. Immun, 70, pp.4669~4677 (2002)
86. Tang B, "Shiga toxins induce autophagic cell death in intestinal epithelial cells via the endoplasmic reticulum stress pathway", Autophagy, 11, pp.344~354 (2015)
87. Braicu C, "A comprehensive review on MAPK : A promising therapeutic target in cancer", Cancers(Basel), 11, pp.1618~ (2019)
88. Kyriakis JM, "Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation", Physiol. Rev, 81, pp.807~869 (2001)
89. Wada T, "Mitogen-activated protein kinases in apoptosis regulation", Oncogene, 23, pp.2838~2849 (2004)
90. Smith WE, "Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells", Infect. Immun, 71, pp.1497~1504 (2003)
91. Cherla RP, "Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1cell line", J. Leukoc. Biol, 79, pp.397~407 (2006)
92. Jandhyala DM, "ZAK : a MAP3Kinase that transduces Shiga toxin and ricin-induced proinflammatory cytokine expression", Cell Microbiol, 10, pp.1468~1477 (2008)
93. Ketelut-Carneiro N, "Apoptosis, pyroptosis, and necroptosis-oh my! the many ways a cell can die", J. Mol. Biol, 434, pp.167378~ (2022)
94. Coll RC, "NLRP3 and pyroptosis blockers for treating inflammatory diseases", Trends Pharmacol. Sci, 43, pp.653~668 (2022)
95. Platnich JM, "Shiga toxin", lipopolysaccharide activates caspase-4 and gasdermin D to trigger mitochondrial reactive oxygen species upstream of the NLRP3 inflammasome, 2018, pp.25, 1525~1536e1527
96. Pinatih KJP, "Shiga-like toxin produced by local isolates of Escherichia coli O157 : H7 induces apoptosis of the T47 breast cancer cell line", Breast Cancer(Auckl), 15, pp.11782234211010120~ (2021)
97. Kim I, "Cell death and endoplasmic reticulum stress : disease relevance and therapeutic opportunities", Nat. Rev. Drug Discov, 7, pp.1013~1030 (2008)
98. Calfon M, "IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA", Nature, 415, pp.92~96 (2002)
99. Lee AH, "XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response", Mol. Cell Biol, 23, pp.7448~7459 (2003)
100. Hetz C, "The unfolded protein response : controlling cell fate decisions under ER stress and beyond", Nat. Rev. Mol. Cell Biol, 13, pp.89~102 (2012)
101. Lee SY, "Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells", Cell. Microbiol, 10, pp.770~780 (2008)
102. Lee KS, "Inhibition of O-GlcNAcylation protects from Shiga toxin-mediated cell injury and lethality in host", EMBO Mol. Med, 14, pp.e14678~ (2022)
103. Parello CS, "Shiga toxin 2-induced endoplasmic reticulum stress is minimized by activated protein C but does not correlate with lethal kidney injury", Toxins(Basel), 7, pp.170~186 (2015)
104. Coe H, "Calcium binding chaperones of the endoplasmic reticulum", Gen. Physiol. Biophys, 28(Spec No Focus), pp.F96~F103. (2009)
105. Kuznetsov G, "Demonstration of a calcium requirement for secretory protein processing and export. Differential effects of calcium and dithiothreitol", J. Biol. Chem, 267, pp.3932~3939 (1992)
106. Sattler R, "Molecular mechanisms of calciumdependent excitotoxicity", J. Mol. Med. (Berl), 78, pp.3~13 (2000)
107. Johansson KE, "Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism", Sci. Rep, 9, pp.14362~ (2019)
108. Kostova EB, "Identification of signalling cascades involved in red blood cell shrinkage and vesiculation", Biosci. Rep, 35, pp.e00187~ (2015)
109. Liu R, "Erythrocyte-derived microvesicles may transfer phosphatidylserine to the surface of nucleated cells and falsely 'mark'them as apoptotic", Eur. J. Haematol, 83, pp.220~229 (2009)
110. Majka M, "Evidence that platelet-derived microvesicles may transfer platelet-specific immunoreactive antigens to the surface of endothelial cells and CD34+ hematopoietic stem", progenitor cells--implication for the pathogenesis of immune thrombocytopenias, 2007, pp.45, 27~32
111. Janowska-Wieczorek A, "Platelet-derived microparticles bind to hematopoietic stem", progenitor cells and enhance their engraftment, 2001, pp.98, 3143~3149
112. Tkach M, "Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes", EMBO J, 36, pp.3012~3028 (2017)
113. Cho BS, "Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis", Stem Cell Res. Ther, 9, pp.187~ (2018)
114. van Niel G, "Shedding light on the cell biology of extracellular vesicles", Nat. Rev. Mol. Cell Biol, 19, pp.213~228 (2018)
115. He C, "Macrophages release plasma membrane-derived particles rich in accessible cholesterol", Proc. Natl. Acad. Sci. USA, 115, pp.E8499~E8508 (2018)
116. Kyoung Mi Kim, "RNA in extracellular vesicles", Wiley Interdisciplinary Reviews: RNA, 8(4), pp.e1413~ (2017), Wiley[DOI]
117. Latifkar A, "New insights into extracellular vesicle biogenesis and function", J. Cell Sci, 132, pp.jcs222406~ (2019)
118. Ståhl AL, "Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome", PLoS One, 4, pp.e6990~ (2009)
119. Arvidsson I, "Shiga toxin-induced complement-mediated hemolysis and release of complementcoated red blood cell-derived microvesicles in hemolytic uremic syndrome", J. Immunol, 194, pp.2309~2318 (2015)
120. Ge S, "Microparticle generation and leucocyte death in Shiga toxin-mediated HUS", Nephrol. Dial. Transplant, 27, pp.2768~2775 (2012)
121. Iordanov MS, "Ribotoxic stress response : activation of the stressactivated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin", ricin loop in the 28S rRNA, 1997, pp.17, 3373~3381
122. Lee MS, "Bcl-2 regulates the onset of shiga toxin 1-induced apoptosis in THP-1 cells", Infect. Immun, 77, pp.5233~5244 (2009)
123. Lim HS, "The anti-neuroinflammatory activity of tectorigenin pretreatment via downregulated NF-kappaB and ERK", JNK pathways in BV-2 microglial and microglia inactivation in mice with lipopolysaccharide, 2018, pp.9, 462~
124. Gray JS, "Double-stranded RNA-activated protein kinase mediates induction of interleukin-8 expression by deoxynivalenol, Shiga toxin 1, and ricin in monocytes", Toxicol. Sci, 105, pp.322~330 (2008)
125. Elliott TS, "The response of Escherichia coli to ciprofloxacin and norfloxacin", J. Med. Microbiol, 23, pp.83~88 (1987)
126. Angel Villegas N, "Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157 : H7and non-O157 biofilms", Toxicol. In Vitro, 29, pp.1692~1700 (2015)
127. Ichinohe N, "Effects of fosfomycin on Shiga toxin-producing Escherichia coli : quantification of copy numbers of Shiga toxin-encoding genes and their expression levels using real-time PCR", J. Med. Microbiol, 58, pp.971~973 (2009)
128. Griffin DE, "Isolation and characterization of monoclonal antibodies to Shiga toxin", Infect. Immun, 41, pp.430~433 (1983)
129. Strockbine NA, "Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli", Infect. Immun, 50, pp.695~700 (1985)
130. Melton-Celsa A, "Pathogenesis of Shiga-toxin producing escherichia coli", Curr. Top. Microbiol. Immunol, 357, pp.67~103 (2012)
131. Cheng LW, "Mouse in vivo neutralization of Escherichia coli Shiga toxin 2with monoclonal antibodies", Toxins(Basel), 5, pp.1845~1858 (2013)
132. Smith MJ, "Monoclonal antibody 11E10, which neutralizes shiga toxin type 2(Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin in vitro, and alters the overall cellular distribution of the toxin", Infect. Immun, 77, pp.2730~2740 (2009)
133. Nakanishi K, "Protection of human colon cells from Shiga toxin by plant-based recombinant secretory IgA", Sci. Rep, 7, pp.45843~ (2017)
134. Ruano-Gallego D, "A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa", PLoS Pathog, 15, pp.e1008031~ (2019)
135. Trachtman H, "Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children : a randomized controlled trial", JAMA, 290, pp.1337~1344 (2003)
136. Nishikawa K, "A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157 : H7", Proc. Natl. Acad. Sci. USA, 99, pp.7669~7674 (2002)
137. Nishikawa K, "Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation", J. Infect. Dis, 191, pp.2097~2105 (2005)
138. Watanabe M, "Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections", J. Infect. Dis, 189, pp.360~368 (2004)
139. LaCasse EC, "Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+)hematopoietic stem cells : implications for ex vivo tumor purging and autologous stem cell transplantation", Blood, 94, pp.2901~2910 (1999)
140. Arab S, "Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias", Oncol. Res, 9, pp.553~563 (1997)
141. Maak M, "Tumor-specific targeting of pancreatic cancer with Shiga toxin B-subunit", Mol. Cancer Ther, 10, pp.1918~1928 (2011)
142. Ohyama C, "Changes in glycolipid expression in human testicular tumor", Int. J. Cancer, 45, pp.1040~1044 (1990)
143. El Alaoui A, "Shiga toxin-mediated retrograde delivery of a topoisomerase I inhibitor prodrug", Angew. Chem. Int. Ed. Engl, 46, pp.6469~6472 (2007)
144. El Alaoui A, "Synthesis and properties of a mitochondrial peripheral benzodiazepine receptor conjugate", ChemMedChem, 3, pp.1687~1695 (2008)
145. Farkas-Himsley H, "The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1", Proc. Natl. Acad. Sci. USA, 92, pp.6996~7000 (1995)
146. Salhia B, "The treatment of malignant meningioma with verotoxin", Neoplasia, 4, pp.304~311 (2002)
147. Heath-Engel HM, "Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model : VT1 as a tumour neovascular marker", Angiogenesis, 6, pp.129~141 (2003)
148. Ishitoya S, "Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice", J. Urol, 171, pp.1309~1313 (2004)
149. Arab S, "Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice", Oncol. Res, 11, pp.33~39 (1999)
150. Palermo MS, "Hemolytic uremic syndrome : pathogenesis and update of interventions", Expert Rev. Anti. Infect. Ther, 7, pp.697~707 (2009)
151. Lee MS, "Shiga toxins activate the NLRP3 inflammasome pathway to promote both production of the proinflammatory cytokine interleukin-1beta and apoptotic cell death", Infect. Immun, 84, pp.172~186 (2016)
152. Shu Q, "Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001(DR20)against Escherichia coli O157 : H7 infection in mice", FEMS Immunol. Med. Microbiol, 34, pp.59~64 (2002)
153. Shu Q, "A dietary probiotic(Bifidobacterium lactis HN019)reduces the severity of Escherichia coli O157 : H7 infection in mice", Med. Microbiol. Immunol, 189, pp.147~152 (2001)

관련 논문AI추천